Anti-Human CD137 (4-1BB)

Leinco Technologies
Product Code: LEI-B591
Product Group: Primary Antibodies
CodeSizePrice
LEI-B591-25ug25 ug£375.00
Quantity:
LEI-B591-100ug100 ug£659.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: IgG2b
Antibody Clonality: Monoclonal
Antibody Clone: 145501
Regulatory Status: RUO
Target Species: Human
Applications:
  • Flow Cytometry
  • Mass Cytometry (CyTOF)
  • Western Blot (WB)
Shipping:
Ambient
Storage:
The lyophilized antibody can be stored desiccated at -20°C to -70°C for up to twelve months. The reconstituted antibody can be stored for at least four weeks at 2-8°C. For long-term storage of the reconstituted antibody aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid repeated freeze thaw cycles. No detectable loss of activity was observed after six months.

Further Information

Antigen Distribution:
4-1BB is expressed on activated B cells and T cells, macrophages, and dendritic cells.
Conjugate/Tag/Label:
Purified No Carrier Protein
Format:
This monoclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.4 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.
Formulation:
This monoclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.4 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.
Immunogen:
NS0-Derived Recombinant Human 4-1BB Extracellular Domain (Accession # Q07011)
Long Description:
4-1BB (CD137) is a 39 kD transmembrane protein that is a member of the tumor necrosis factor (TNF) receptor family and is a co-stimulatory molecule that plays a role in T-cell-mediated proliferative response. When binding its ligand, CD137 provides costimulatory signals to both CD4 and CD8 T cells via the activation of NF-?B, c-Jun and p38 downstream pathways. Crosslinking of CD137 boosts T cell proliferation, IL-2 secretion, survival and cytolytic activity. Furthermore, it can increase immune activity to eliminate tumors in mice. Agonistic anti-CD137 antibodies have been reported to stimulate a more intense immune system attack on cancers.
NCBI Gene:
3604
Target:
CD137

References

1. Shan, B. et al. (2008) Cell Mol Immunol. 5: 379 2. Kwan, BS. et al. (2009) J Immunol. 182: 4107 3. Kwan, BS. et al. (1998) Eur J Immunol. 28: 881 4. Kwan, BS. et al. (1996) Cell Immunol. 169: 91